pARS3_MUbCAS9_GW
(Plasmid
#128646)
-
Purpose(Empty Backbone) T-DNA binary vector for CRISPR/Cas9 gene editing in rice; has a Gateway cassette for cloning gRNA
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 128646 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepARS3
-
Backbone manufacturerThilmony,R.
- Backbone size (bp) 7000
-
Modifications to backboneThe T-DNA portion of the vector incorporates a transformation booster sequence (TBS), a plant-codon-optimized hemagglutinin (HA)- tagged nuclear-localized Cas9 gene (Cas9-HA-N7), driven by the Zea mays UBQ10 promoter and containing a ribosomal-binding site (RBS), and OCS terminator. Gateway cassette from pEarlyGate103 was added to allow Gateway cloning of gRNAs.
-
Vector typePlant Expression
-
Selectable markersHygromycin
-
Tag
/ Fusion Protein
- HA
Growth in Bacteria
-
Bacterial Resistance(s)Chloramphenicol and Kanamycin, 25 & 50 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)ccdB Survival
-
Growth instructionsIt is growing slower due to big size.
-
Copy numberHigh Copy
Resource Information
-
Supplemental Documents
-
A portion of this plasmid was derived from a plasmid made byAll features but Gateway cassette was cloned into pARS3m vector in Zachary Nimchuk lab
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pARS3_MUbCAS9_GW was a gift from G. Eric Schaller (Addgene plasmid # 128646 ; http://n2t.net/addgene:128646 ; RRID:Addgene_128646) -
For your References section:
Type-B response regulators of rice play key roles in growth, development, and cytokinin signaling. Worthen JM, Yamburenko MV, Lim J, Nimchuk ZL, Kieber JJ, Schaller GE. Development. 2019 Jun 3. pii: dev.174870. doi: 10.1242/dev.174870. 10.1242/dev.174870 PubMed 31160418